Medicare Enrolled
Dr. Mina Mikhail, MD
Internal Medicine · Riverside, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mikhail from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mikhail?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mikhail
Dr. Mina Mikhail is an internal medicine specialist in Riverside, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mikhail performed 2,548 Medicare services across 1,101 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mikhail received a total of $5,854 from 47 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mikhail is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$5,854 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,548
Medicare services
Top 13% in CA for internal medicine
1,101
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~134 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
809 | $96 | $275 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
516 | $94 | $177 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
239 | $125 | $275 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
208 | $62 | $133 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
170 | $93 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
133 | $136 | $375 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
104 | $83 | $250 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
88 | $172 | $420 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
41 | $98 | $100 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
40 | $148 | $380 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
36 | $32 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
36 | $32 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $129 | $256 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
26 | $169 | $325 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
21 | $218 | $483 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
19 | $11 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $117 | $291 |
| New patient office visit, complex (60-74 min) | 11 | $180 | $370 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,854
Total received (2018-2024)
Avg $836/year across 7 years
Top 14% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,854 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$870
2023
$642
2022
$1,225
2021
$941
2020
$401
2019
$669
2018
$1,106
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$270
Novartis Pharmaceuticals Corporation
$138
Abbott Laboratories
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
Janssen Pharmaceuticals, Inc
$58
ABBVIE INC.
$51
Esperion Therapeutics, Inc.
$35
Merck Sharp & Dohme LLC
$32
Lilly USA, LLC
$29
Exact Sciences Corporation
$27
GlaxoSmithKline, LLC.
$24
Novo Nordisk Inc
$18
Medtronic, Inc.
$15
Top 3 companies account for 58.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$838
Novo Nordisk Inc
$592
Novartis Pharmaceuticals Corporation
$373
Amgen Inc.
$343
Boehringer Ingelheim Pharmaceuticals, Inc.
$331
Abbott Laboratories
$301
GlaxoSmithKline, LLC.
$273
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$266
Lilly USA, LLC
$249
Nestle HealthCare Nutrition Inc.
$244
Merck Sharp & Dohme LLC
$227
PFIZER INC.
$210
Merck Sharp & Dohme Corporation
$209
Janssen Pharmaceuticals, Inc
$155
E.R. Squibb & Sons, L.L.C.
$153
SANOFI-AVENTIS U.S. LLC
$152
Esperion Therapeutics, Inc.
$109
ABBVIE INC.
$74
Allergan Inc.
$64
Melinta Therapeutics, Inc.
$61
AbbVie Inc.
$50
Bayer HealthCare Pharmaceuticals Inc.
$36
Amarin Pharma Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$32
INTERCEPT PHARMACEUTICALS, INC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$30
Biohaven Pharmaceuticals, Inc.
$29
Breathe Technologies, Inc.
$28
Exact Sciences Corporation
$27
IRONWOOD PHARMACEUTICALS, INC
$26
Eisai Inc.
$24
Otsuka America Pharmaceutical, Inc.
$24
Sunovion Pharmaceuticals Inc.
$22
IDORSIA PHARMACEUTICALS US INC
$22
Boston Scientific Corporation
$21
Astellas Pharma US Inc
$20
Xeris Pharmaceuticals, Inc.
$20
Medtronic USA, Inc.
$19
Allergan, Inc.
$18
Scilex Pharmaceuticals Inc.
$17
VIVUS, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
Medtronic, Inc.
$15
Seqirus USA Inc
$14
NESTLE HEALTHCARE NUTRITION INC.
$14
Optos, Inc.
$12
Biohaven Pharmaceutical Holding Company Ltd.
$12
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · AVYCAZ · Aimovig · Amitiza · BELSOMRA · BREO · BREZTRI · BRILINTA · Baxdela · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DALVANCE · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · Edarbi · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · GVOKE PFS · INVOKANA · JANUVIA · JARDIANCE · KYPHON Balloon Kyphoplasty · Kerendia · LEQVIO · LINQ II · LINZESS · LYRICA · Life2000 Ventilation System · Linzess · MOUNJARO · NEXLETOL · NURTEC ODT · OCALIVA · OCT OPHTHALMOSCOPE · Orbactiv · Otezla · Ozempic · PANCREAZE · PRALUENT · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SAMSCA · SHINGRIX · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · UBRELVY · VERQUVO · VESICARE · VIBERZI · Vascepa · Verquvo · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZENPEP · ZERBAXA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,166
Per 100K population
47.6
County median income
$89,672
Nearest hospital
PACIFIC GROVE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mikhail is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mikhail experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Mikhail performed 809 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mikhail receive payments from pharmaceutical companies?
Yes. Dr. Mikhail received a total of $5,854 from 47 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mikhail's costs compare to other internal medicine physicians in Riverside?
Dr. Mikhail's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mikhail) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Riverside
Browse internal medicine physicians in Riverside ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology